Formosa Laboratories, Inc. is a Taiwanese company specializing in the production of APIs and UV-filter chemicals. Established in 1995, the company operates modern facilities near Taipei and has gained recognition for its high-quality products. Notably, Formosa Laboratories, Inc. boasts GMP compliance approved by various regulatory bodies, including the DOH of Taiwan, US FDA, BGV of Germany, EDQM, and PMDA of Japan. The company's extensive line of APIs encompasses an array of products such as Vitamin D derivatives, Balsalazide, Benzonatate, and Montelukast, positioning it as a major global producer in the pharmaceutical arena. In addition, the company offers custom synthesis services for APIs and specialty chemicals, along with comprehensive documentation support. Despite promising prospects and a strong position in the biotechnology, manufacturing, and pharmaceutical sectors, information regarding its recent investment and investors is not available.
There is no investment information
No recent news or press coverage available for Formosa Laboratories, Inc..